Compounds > bohemine

bohemine and cyc 202

bohemine has been researched along with cyc 202 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Havlícek, L; Krystof, V; Kuzma, M; Lenobel, R; Strnad, M1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Bravo-Altamirano, K; DeStefino, NR; Liang, M; Mazzarisi, CM; Meriney, SD; Olszewski, RA; Rensch, G; Swanson, L; Tarr, TB; Valdomir, G; Wilson, GM; Wipf, P1
Bazgier, V; Berka, K; Gucký, T; Havlíček, L; Jaffe, CL; Jorda, R; Kryštof, V; Nasereddin, A; Popa, A; Popa, I; Řezníčková, E; Strnad, M; Zatloukal, M1
Binarová, P; Bögre, L; Dolezel, J; Draber, P; Heberle-Bors, E; Strnad, M1
Fischer, PM; Goddard, PM; Lane, DP; Nutley, BP; Raynaud, FI; Workman, P1
Adona, PR; Lima Verde Leal, C1
Barrie, SE; Brunton, L; Clarke, SJ; Eccles, S; Fischer, PM; Garrett, MD; Kelland, LR; Lane, DP; McClue, S; Raynaud, FI; Rogers, P; Valenti, M; Walton, MI; Whittaker, SR; Workman, P1
An, R; Hagiya, Y; Ishikawa, T; Li, S; Saito, H; Tamura, A; Tokushima, D1
Cwiertka, K; Dzubak, P; Hajduch, M; Korinkova, G; Paprskarova, M1

Other Studies

10 other study(ies) available for bohemine and cyc 202

ArticleYear
Synthesis and biological activity of olomoucine II.
    Bioorganic & medicinal chemistry letters, 2002, Nov-18, Volume: 12, Issue:22

    Topics: Antineoplastic Agents; CDC2 Protein Kinase; CDC28 Protein Kinase, S cerevisiae; Cell Survival; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Kinetin; Purines; Roscovitine; Structure-Activity Relationship; Tumor Cells, Cultured

2002
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist.
    ACS medicinal chemistry letters, 2012, Dec-13, Volume: 3, Issue:12

    Topics:

2012
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.
    Bioorganic & medicinal chemistry letters, 2015, Jun-01, Volume: 25, Issue:11

    Topics: Antiprotozoal Agents; Binding Sites; Leishmania donovani; Leishmania major; Models, Molecular; Molecular Structure; Protein Binding; Protein Conformation; Proto-Oncogene Proteins c-crk; Purines; Structure-Activity Relationship

2015
Treatment of Vicia faba root tip cells with specific inhibitors to cyclin-dependent kinases leads to abnormal spindle formation.
    The Plant journal : for cell and molecular biology, 1998, Volume: 16, Issue:6

    Topics: Calcium-Calmodulin-Dependent Protein Kinases; CDC2 Protein Kinase; Cell Cycle; Cyclin A; Cyclin B; Enzyme Inhibitors; Fabaceae; Meristem; Microtubules; Plant Roots; Plants, Medicinal; Protein Kinases; Purines; Roscovitine; Spindle Apparatus; Transcription, Genetic

1998
Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:3

    Topics: Animals; Area Under Curve; CDC2-CDC28 Kinases; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Free Radicals; Gene Library; Mice; Mice, Inbred BALB C; Models, Chemical; Neoplasms; Purines; Roscovitine; Structure-Activity Relationship; Time Factors

2004
Meiotic inhibition with different cyclin-dependent kinase inhibitors in bovine oocytes and its effects on maturation and embryo development.
    Zygote (Cambridge, England), 2004, Volume: 12, Issue:3

    Topics: 4-Butyrolactone; Animals; Cattle; Cyclin-Dependent Kinases; Embryo, Mammalian; Meiosis; Oocytes; Purines; Roscovitine

2004
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-01, Volume: 11, Issue:13

    Topics: Animals; Area Under Curve; Blotting, Western; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Enzyme Inhibitors; Female; HCT116 Cells; Humans; Inhibitory Concentration 50; Kinetin; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Phosphorylation; Purines; Recombinant Proteins; Retinoblastoma Protein; Roscovitine; Time Factors; Tissue Distribution; Xenograft Model Antitumor Assays

2005
Cellular phototoxicity evoked through the inhibition of human ABC transporter ABCG2 by cyclin-dependent kinase inhibitors in vitro.
    Pharmaceutical research, 2009, Volume: 26, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Cell Survival; Chlorophyll; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Hematoporphyrins; Humans; Kinetin; Models, Molecular; Molecular Conformation; Molecular Structure; Neoplasm Proteins; Photosensitizing Agents; Protein Kinase Inhibitors; Purines; Quantitative Structure-Activity Relationship; Quinazolines; Roscovitine; Spodoptera; Transfection

2009
The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.
    Neoplasma, 2010, Volume: 57, Issue:2

    Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Cell Cycle; Cyclin-Dependent Kinases; Flow Cytometry; Humans; Kinetin; Lung Neoplasms; Protein Kinase Inhibitors; Purines; Radiation-Sensitizing Agents; Roscovitine; Tumor Cells, Cultured; X-Rays

2010